HealthXBB.1.5: What we know so far about the latest omicron subvariant A highly transmissible covid-19 subvariant called XBB.1.5 is now the dominant cause of covid-19 infections in the US – but there’s no evidence it causes more serious illness News
HealthDrug that targets ACE2 receptors may work against new covid variants A drug that is approved for treating gallstones and liver conditions inhibits cells' ACE2 receptors, which the coronavirus' spike protein binds to News